Dacomitinib Impurities and its Related Products

Displaying 2 results of Dacomitinib Impurities

Dacomitinib is an investigational drug used in the treatment of non-small cell lung cancer. It is important to ensure that the drug is pure and free of impurities that can affect its safety and efficacy. Dacomitinib impurities are defined as any substance present in the drug substance that is not the active pharmaceutical ingredient. These impurities can arise during the manufacturing process, storage, or transportation. It is essential to monitor and control the levels of impurities in dacomitinib to


DACOMITINIB IMPURITIES, IMPURITIES
1-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one


CAT No. : CS-O-37056
Mol F. : C19H16ClFN4O3
Mol W. : 402.81 g/mol
Cas No. : 2190490-31-2
Stock : Enquire

DACOMITINIB IMPURITIES, IMPURITIES
Dacomitinib d10


CAT No. : CS-EO-02775
Mol F. : C₂₄H₁₅D₁₀ClFN₅O₂
Mol W. : 480.00 g/mol
Cas No. : 1110813-31-4 (Unlabelled)
Stock : IN-Stock